Serotonin–norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption

Depressive symptoms and rates of bone loss at the hip in older men

(2012) S. J. Diem et al.   OSTEOPOROSIS INTERNATIONAL

Prevalence and Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States

(2011) Swapna U. Karkare et al.   American Journal Geriatric Pharmacotherapy

Use of Antidepressant Medications and Risk of Fracture in Older Women

(2011) Susan J. Diem et al.   CALCIFIED TISSUE INTERNATIONAL

Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women

(2011) Hasan Aydin et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Depression, Antidepressants, and Bone Mineral Density in a Population-Based Cohort

(2011) B. Mezuk et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels

(2010) Stuart J. Warden et al.   BONE

Risk of Low Bone Mineral Density Associated With Psychotropic Medications and Mental Disorders in Postmenopausal Women

(2010) James M. Bolton et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

National Patterns in Antidepressant Medication Treatment

(2009) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5)

(2009) Stuart J. Warden et al.   BONE

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

(2009) Lana J. Williams et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Bone turnover markers: understanding their value in clinical trials and clinical practice

(2009) R. Civitelli et al.   OSTEOPOROSIS INTERNATIONAL

Sample sizes required to detect interactions between two binary fixed-effects in a mixed-effects linear regression model

(2008) Andrew C. Leon et al.   COMPUTATIONAL STATISTICS & DATA ANALYSIS

Depressive Symptoms, Bone Loss, and Fractures in Postmenopausal Women

(2008) Leslie Spangler et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency

(2008) Stuart J. Warden et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis

(2008) P. Szulc et al.   OSTEOPOROSIS INTERNATIONAL

A detailed examination of cytokine abnormalities in Major Depressive Disorder

(2007) N.M. Simon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation

(2007) C. Collet et al.   FASEB JOURNAL